Federated Hermes, Inc. Inovio Pharmaceuticals, Inc. Transaction History

Federated Hermes, Inc.

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	BUY	$0.79 - $1.91 $1,431 - $3,460	1,812 Added 137.9%	3,126 $2,000
Q4 2022 Feb 13, 2023	SELL	$1.41 - $2.5 $896 - $1,590	-636 Reduced 32.62%	1,314 $2,000
Q3 2022 Nov 14, 2022	SELL	$1.66 - $2.79 $856 - $1,439	-516 Reduced 20.92%	1,950 $4,000
Q2 2022 Aug 15, 2022	BUY	$1.44 - $3.98 $2,723 - $7,526	1,891 Added 328.87%	2,466 $4,000
Q1 2022 May 13, 2022	BUY	$2.97 - $5.2 $1,707 - $2,990	575 New	575 $2,000
Q4 2020 Feb 12, 2021	SELL	$8.5 - $12.85 $221 - $334	-26 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$9.57 - $27.05 $934,701 - $2.64 Million	-97,670 Reduced 99.97%	26 $1,000
Q2 2020 Aug 13, 2020	BUY	$7.14 - $31.69 $696,007 - $3.09 Million	97,480 Added 45129.63%	97,696 $2.63 Million
Q1 2020 May 13, 2020	BUY	$2.98 - $14.09 $643 - $3,043	216 New	216 $2,000
Q4 2019 Feb 14, 2020	SELL	$1.97 - $3.72 $1,526 - $2,883	-775 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$2.05 - $3.02 $6,951 - $10,240	-3,391 Reduced 81.4%	775 $2,000
Q1 2019 May 10, 2019	SELL	$3.34 - $5.1 $353,144 - $539,233	-105,732 Reduced 96.21%	4,166 $16,000
Q4 2018 Feb 13, 2019	BUY	$3.89 - $6.11 $421,267 - $661,682	108,295 Added 6755.77%	109,898 $439,000
Q3 2018 Nov 13, 2018	BUY	$3.92 - $5.58 $6,283 - $8,944	1,603 New	1,603 $9,000
Q1 2018 May 09, 2018	SELL	$4.05 - $5.69 $7,423 - $10,429	-1,833 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$4.13 - $6.68 $202 - $327	-49 Reduced 2.6%	1,833 $0
Q3 2017 Nov 13, 2017	BUY	$5.36 - $6.37 $10,087 - $11,988	1,882	1,882 $12,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $494M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.